These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16876848)

  • 21. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
    Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
    Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
    PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
    Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cells and herpesviruses: a model of lymphoproliferation.
    Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Forghieri F; Torelli G; Luppi M
    Autoimmun Rev; 2007 Dec; 7(2):132-6. PubMed ID: 18035323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
    Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
    Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and genotypic characteristics of new euploid-diploid lymphoblastoid B cell lines EBV+, normal human bone marrow derived, spontaneously overgrown in vitro.
    Bertolini L; Aebischer ML; Ameglio F; Angeloni A; Delaroche I; Faggioni A; Fruscalzo A; Gorini G; Serafino A; Starace G; Tabilio A
    J Virol Methods; 2005 Jun; 126(1-2):91-100. PubMed ID: 15847924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase.
    Kloster MM; Hafte TT; Moltzau LR; Naderi EH; Dahle MK; Skålhegg BS; Gaudernack G; Levy FO; Naderi S; Blomhoff HK
    Cell Signal; 2008 Jun; 20(6):1169-78. PubMed ID: 18406106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder.
    Takegawa S; Jin Z; Nakayama T; Oyama T; Hieshima K; Nagakubo D; Shirakawa AK; Tsuzuki T; Nakamura S; Yoshie O
    Cancer Sci; 2008 Feb; 99(2):296-302. PubMed ID: 18271928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Cancer Sci; 2008 Aug; 99(8):1633-42. PubMed ID: 18754877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
    Knight JS; Sharma N; Robertson ES
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18562-6. PubMed ID: 16352731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of EBV transforming genes by recombinant EBV technology.
    Izumi KM
    Semin Cancer Biol; 2001 Dec; 11(6):407-14. PubMed ID: 11669602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.
    Knight JS; Robertson ES
    J Virol; 2004 Feb; 78(4):1981-91. PubMed ID: 14747563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.